The activation of EphB2 is accompanied by the activation of ERK in DRG neurons after nerve injury, and intrathecal administration of EphB2 receptor blocker can inhibit nerve injury-induced pain and ERK activation (Ma et al., 2020; Poliakov et al., 2008b). The gene discussed is EPHB2; the disease is injury.